How Startup Valuation Actually Works
Pre-money, post-money, and why early-stage valuation is negotiated rather than calculated. The methods investors use, what really moves the number, and why chasing a high valuation can backfire.
Start with the mechanics
Two terms, and almost every confusion about valuation comes from mixing them up.
Pre-money valuation is what the company is agreed to be worth before new money arrives.
Post-money valuation is pre-money plus the new investment.
Post-money = Pre-money + Investment
Investor ownership % = Investment / Post-money
Worked example. You raise ₹5,00,00,000 at a pre-money valuation of ₹20,00,00,000.
- Post-money: ₹25,00,00,000
- Investor owns: 5 / 25 = 20%
- You and existing shareholders: 80%
Now the same raise quoted as a ₹20 crore post-money valuation:
- Pre-money: ₹15,00,00,000
- Investor owns: 5 / 20 = 25%
Identical headline number, five percentage points of difference in your ownership. When a valuation is quoted to you, establish which one is meant before you react to it.
Why early-stage valuation is not a calculation
There is a real temptation to believe that somewhere there is a correct formula and the investor knows it. There is not.
The standard valuation methods all need inputs an early-stage startup does not have:
- Discounted cash flow requires reliable future cash flows. A pre-revenue company's projections are a narrative with numbers attached.
- Revenue or EBITDA multiples require revenue or EBITDA.
- Comparable transactions require enough similar deals, and terms are frequently not public.
So early-stage valuation is set by negotiation, anchored on what comparable companies at the same stage in the same market recently raised at. It is a market price, not a computed value.
This is genuinely freeing to understand. You are not trying to discover a number. You are negotiating one.
What actually moves the number
In rough order of influence at pre-seed and seed:
Competition for the deal. More than anything else. Two interested investors move a valuation more than any metric. One interested investor sets the price.
The team. A second-time founder with an exit raises at a different price than a first-timer with the same idea. Domain expertise, a track record of shipping, and a complete founding team all move it.
Traction, whatever form it takes. Revenue if you have it. If not: growth rate, retention, waitlist, pilot conversions, letters of intent, usage depth.
Market size and timing. A large market with a visible reason it is opening now supports a higher number than a good business in a small market.
Stage norms in your geography. Indian seed rounds price differently from Bay Area seed rounds for the same company. This is a fact about capital supply, not about quality.
How much you are raising. Valuation and round size are linked through dilution. Raising more at the same valuation means giving up more.
The methods investors reach for anyway
Even where they are imperfect, these frame conversations.
Comparable transactions. What did similar companies at this stage raise at recently? The most commonly used approach in practice.
The scorecard method. Start from a regional average valuation for the stage and adjust up or down for team, market, product, competition and traction. Used by angel groups.
Berkus method. Assigns a value to each of five elements - sound idea, prototype, quality team, strategic relationships, product rollout - capped at a maximum. Blunt, but it makes the reasoning explicit.
Venture capital method. Work backwards from an exit. Estimate exit value, apply the return multiple the fund needs, discount back to today. This is closer to how a fund actually thinks: not "what is this worth" but "can this return my fund?"
Revenue multiples. Once there is meaningful recurring revenue, ARR multiples become the anchor. What multiple depends heavily on growth rate and retention - a company growing 150% with 120% net revenue retention commands a different multiple from one growing 40%.
Dilution across rounds
The number that matters more than any single valuation is what you own at the end.
Illustrative path, assuming a 15% ESOP pool created early and no participation in later rounds:
| Round | Raised | Post-money | New investor % | Founders' combined % |
|---|---|---|---|---|
| Founding | - | - | - | 100% |
| ESOP pool | - | - | 15% | 85% |
| Seed | ₹4 Cr | ₹20 Cr | 20% | 68% |
| Series A | ₹25 Cr | ₹125 Cr | 20% | 54% |
| Series B | ₹80 Cr | ₹500 Cr | 16% | 46% |
Founders commonly hold somewhere in the region of 40–55% after a Series B. That is normal and not a failure. What matters is that each round bought enough progress to justify the dilution.
Two things that quietly worsen this: convertible instruments you have forgotten about, which convert and dilute at the next priced round, and ESOP pool top-ups, which are frequently required at each round and dilute existing shareholders only.
Why a high valuation can hurt you
This is the part founders learn late.
You have to grow into it. A valuation is a promise about the future. Raise at ₹200 crore on ₹2 crore of ARR and your Series B needs metrics that justify substantially more than ₹200 crore. If you do not get there, the next round is flat or down.
Down rounds are expensive. Beyond the signalling damage, anti-dilution provisions in earlier rounds can trigger, diluting founders and employees disproportionately. Option grants issued at the old valuation go underwater, and your team notices.
It narrows your investor pool. Each fund has a stage and cheque size it operates in. Pricing above your stage can put you in a gap where seed funds think you are too expensive and Series A funds think you are too early.
It can make an acquisition harder. An acquirer has to clear the preference stack. A high valuation with structured terms can make an otherwise attractive exit unattractive to everyone holding common stock.
Raising at a valuation you comfortably outgrow, from an investor you want, is a better outcome than the highest number available.
Terms that matter as much as the valuation
A high valuation with bad terms is often worse than a lower valuation with clean ones. Watch for:
- Liquidation preference above 1×, or participating preferred - determines who gets paid what in an exit
- Anti-dilution - full ratchet is punitive; broad-based weighted average is standard
- Board composition and control - who can block what
- Pro-rata rights - whether investors can maintain their stake
- ESOP pool sizing and who bears the dilution - frequently negotiated as part of the valuation and frequently overlooked
Ask what the pre-money valuation is, then ask what the preference stack looks like. The second question tells you more.
The one-line summary
Early-stage valuation is a negotiated market price, not a calculated value, and it is driven mostly by competition for the deal. Establish whether a quoted number is pre- or post-money, look at the terms alongside it, and aim for a valuation you will clearly outgrow rather than the largest one you can get.
Frequently asked questions
- What is the difference between pre-money and post-money valuation?
- Pre-money is the company's agreed value before the new investment goes in. Post-money is pre-money plus the amount invested. If you raise ₹5 crore at a ₹20 crore pre-money valuation, post-money is ₹25 crore and the investor owns 20%.
- How is an early-stage startup with no revenue valued?
- Largely by negotiation, benchmarked against comparable deals at the same stage in the same market. Team, traction signals, market size and competition for the deal drive it far more than any financial model. Nobody is running a discounted cash flow on a pre-revenue company.
- Is a higher valuation always better?
- No. A valuation you cannot grow into sets up a down round later, which is damaging to morale, to your cap table and to your ability to raise again. Raising at a sensible valuation you clearly outgrow is a stronger position than raising at a peak you then have to defend.
